New Jersey may soon require health insurance providers to cover biomarker testing — which can detect evidence of disease-causing genes. Biomarker testing involves checking patient samples for these signs of certain diseases and conditions.

In October, a New Jersey Assembly committee voted to advance a bill that would require insurers to cover biomarker testing. If the Legislature passes the bill, it would expand coverage for screenings and tests that detect cancer, Alzheimer’s, and a range of other diseases and behavioral health conditions.

Originally published on insurify.com, part of the BLOX Digital Content Exchange.

Recommended for you